Treatment of necrotizing acute pancreatitis with peritoneal lavage and dialysis by a new simplified technique insert catheters: One retrospective study

An analysis of the "Half-Perc" versus open surgical placement method for a peritoneal dialysis catheter: a non-inferiority cohort study

Background

Most end-stage renal disease (ESRD) patients undergo open surgical techniques for peritoneal dialysis (PD) catheter placement. An alternative method to PD catheter implantation is the half-percutaneous (“Half-Perc”) technique based on a modified trocar that is performed by a nephrologist. The single-center, retrospective, observational, cohort study presented here aimed to compare the effects of the “Half-Perc” technique with the traditional open surgery on peritoneal catheter insertion.

Methods

From January 2015 to January 2018, 240 ESRD patients who received initial PD catheter placement were divided into two groups based on the “Half-Perc” technique or open surgery. All patients were followed up for 365 days or until loss of initial PD catheter or death. Prism 5 software was used to analyze baseline characteristics, operation-related parameters, mechanical complications and clinical outcomes.

Results

The “Half-Perc” technique showed shorter operation time, shorter incision length, lower postoperative pain scores and quick initiation of the PD program compared to the open surgery. After the 365-day follow-up, the “Half-Perc” group showed a higher rate of catheter dysfunction (4% versus 0.9%) that was corrected by conservative treatment in most patients and a lower rate of peritonitis (4% versus 9.6%) but mechanical complications and clinical outcomes did not differ between the two groups. There was also no significant difference based on overall patient mortality or catheter removal. One-year initial catheter survival and true catheter survival were not statistically different between the groups.

Conclusion

The “Half-Perc” placement of the PD catheter using a modified metal trocar appears to be a non-inferior alternative method and carries minimal invasiveness and risk compared to open surgical placement.

Optimal dosing time of Dachengqi decoction for protection of extrapancreatic organs in rats with experimental acute pancreatitis

BACKGROUND

Acute pancreatitis (AP) is a pancreatic inflammatory disorder that is commonly complicated by extrapancreatic organ dysfunction. Dachengqi decoction (DCQD) has a potential role in protecting the extrapancreatic organs, but the optimal oral administration time remains unclear.

AIM

To screen the appropriate oral administration time of DCQD for the protection of extrapancreatic organs based on the pharmacokinetics and pharmacodynamics of AP rats.

METHODS

This study consisted of two parts. In the first part, 24 rats were divided into a sham-operated group and three model groups. The four groups were intragastrically administered with DCQD (10 g/kg) at 4 h, 4 h, 12 h, and 24 h postoperatively, respectively. Tail vein blood was taken at nine time points after administration, and then the rats were euthanized and the extrapancreatic organ tissues were immediately collected. Finally, the concentrations of the major DCQD components in all samples were detected. In the second part, 84 rats were divided into a sham-operated group, as well as 4 h, 12 h, and 24 h treatment groups and corresponding control groups (4 h, 12 h, and 24 h control groups). Rats in the treatment groups were intragastrically administered with DCQD (10 g/kg) at 4 h, 12 h, and 24 h postoperatively, respectively, and rats in the control groups were administered with normal saline at the same time points. Then, six rats from each group were euthanized at 4 h and 24 h after administration. Serum amylase and inflammatory mediators, and pathological scores of extrapancreatic organ tissues were evaluated.

RESULTS

For part one, the pharmacokinetic parameters (C max, T max, T 1/2, and AUC 0 → t) of the major DCQD components and the tissue distribution of most DCQD components were better when administering DCQD at the later (12 h and 24 h) time points. For part two, delayed administration of DCQD resulted in lower IL-6 and amylase levels and relatively higher IL-10 levels, and pathological injury of extrapancreatic organ tissues was slightly less at 4 h after administration, while the results were similar between the treatment and corresponding control groups at 24 h after administration.

CONCLUSION

Delayed administration of DCQD might reduce pancreatic exocrine secretions and ameliorate pathological injury in the extrapancreatic organs of AP rats, demonstrating that the late time is the optimal dosing time.

Erratum: Medicine, Volume 95, Issue 23: Erratum

[This corrects the article DOI: 10.1097/MD.0000000000003588.][This corrects the article DOI: 10.1097/MD.0000000000003661.][This corrects the article DOI: 10.1097/MD.0000000000003679.][This corrects the article DOI: 10.1097/MD.0000000000003711.][This corrects the article DOI: 10.1097/MD.0000000000003768.][This corrects the article DOI: 10.1097/MD.0000000000003778.][This corrects the article DOI: 10.1097/MD.0000000000003803.][This corrects the article DOI: 10.1097/MD.0000000000003821.][This corrects the article DOI: 10.1097/MD.0000000000003828.][This corrects the article DOI: 10.1097/MD.0000000000003832.][This corrects the article DOI: 10.1097/MD.0000000000003833.][This corrects the article DOI: 10.1097/MD.0000000000003834.][This corrects the article DOI: 10.1097/MD.0000000000003835.][This corrects the article DOI: 10.1097/MD.0000000000003836.][This corrects the article DOI: 10.1097/MD.0000000000003838.][This corrects the article DOI: 10.1097/MD.0000000000003841.][This corrects the article DOI: 10.1097/MD.0000000000003844.][This corrects the article DOI: 10.1097/MD.0000000000003849.][This corrects the article DOI: 10.1097/MD.0000000000003855.][This corrects the article DOI: 10.1097/MD.0000000000003856.][This corrects the article DOI: 10.1097/MD.0000000000003858.][This corrects the article DOI: 10.1097/MD.0000000000003868.][This corrects the article DOI: 10.1097/MD.0000000000003870.][This corrects the article DOI: 10.1097/MD.0000000000003877.][This corrects the article DOI: 10.1097/MD.0000000000003883.][This corrects the article DOI: 10.1097/MD.0000000000003886.][This corrects the article DOI: 10.1097/MD.0000000000003887.][This corrects the article DOI: 10.1097/MD.0000000000003738.][This corrects the article DOI: 10.1097/MD.0000000000003777.][This corrects the article DOI: 10.1097/MD.0000000000003853.][This corrects the article DOI: 10.1097/MD.0000000000003859.][This corrects the article DOI: 10.1097/MD.0000000000003784.][This corrects the article DOI: 10.1097/MD.0000000000003874.].